Status:
RECRUITING
Physical Activity and Sedentary Behavior During Pregnancy
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Réseau de Santé en Périnatalité d'Auvergne
ASM Omnisports - Pôle Sport-Santé
Conditions:
Pregnant Woman
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Our main objective is to evaluate the intervention that best enables women's adherence to physical activity (PA). Our hypothesis is that identifying types of interventions suitable for pregnant women...
Detailed Description
PA has beneficial effects on physical, psychological, and social health, and its regular practice helps to prevent numerous chronic diseases. During pregnancy, PA also has many benefits for women's ph...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Pregnant women of more of 18 years and who are being monitored for pregnancy in the Clermont-Ferrand metropolitan area,
- Planned to give birth in a maternity unit localized in Clermont-Ferrand metropolitan area (CHU Estaing or Clinique de la Chataigneraie),
- Agreeing to be randomized, to follow the physical activity program offered in the Clermont-Ferrand metropolitan area, and to follow up as part of the study,
- Able to give informed consent to participate in the research,
- Affiliated to a social security scheme
- And between 14+0d and 21+6d weeks of gestation.
- Non inclusion Criteria:
- Women under guardianship, curators, deprived of liberty or under court protection,
- With a history of recurrent miscarriage,
- Presenting a multiple pregnancy,
- Hemoglobinemia \<9g/dL or symptomatic anemia,
- Presenting eating disorders or a BMI ≤ 18.5 or a BMI ≥ 40,
- With orthopedic limitations,
- Presenting cardiovascular or pulmonary disease,
- Uncontrolled thyroid disease,
- Presenting a high level of smoking,
- With significant health problems,
- Premature rupture of membranes,
- Premature labor during this pregnancy or a history of at least 2 premature births,
- Persistent vaginal bleeding,
- Cervical incompetence,
- Evidence of intrauterine growth restriction,
- Uncontrolled epilepsy,
- Diabetes (previous or gestational, diagnosed in the 1st trimester) or chronic hypertension,
- Or having a planned home birth.
Exclusion
Key Trial Info
Start Date :
September 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
630 Patients enrolled
Trial Details
Trial ID
NCT06585085
Start Date
September 10 2024
End Date
October 1 2027
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000